Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

alpha-fetoprotein expression in a dedifferentiated liposarcoma.

Bosco M, Allia E, Coindre JM, Odasso C, Pagani A, Pacchioni D.

Virchows Arch. 2006 Apr;448(4):517-20. Epub 2006 Feb 18.

PMID:
16489442
2.

Overlapping features between dedifferentiated liposarcoma and undifferentiated high-grade pleomorphic sarcoma.

Chung L, Lau SK, Jiang Z, Loera S, Bedel V, Ji J, Weiss LM, Chu PG.

Am J Surg Pathol. 2009 Nov;33(11):1594-600. doi: 10.1097/PAS.0b013e3181accb01.

PMID:
19574885
3.

Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.

Yoshida A, Ushiku T, Motoi T, Shibata T, Fukayama M, Tsuda H.

Am J Surg Pathol. 2010 Sep;34(9):1361-6. doi: 10.1097/PAS.0b013e3181ebcc45.

PMID:
20697254
4.

Dedifferentiated liposarcoma with rhabdomyoblastic differentiation.

Shimada S, Ishizawa T, Ishizawa K, Kamada K, Hirose T.

Virchows Arch. 2005 Nov;447(5):835-41. Epub 2005 Jul 13.

PMID:
16012847
5.

Retroperitoneal dedifferentiated liposarcoma with osteosarcomatous components: a case report.

Fujii T, Arai T, Sakon M, Sawano S, Momose Y, Ishii K, Miwa S.

Int J Clin Exp Pathol. 2013 Jun 15;6(7):1427-31. Print 2013.

6.

Dedifferentiated liposarcomas with divergent myosarcomatous differentiation developed in the internal trunk: a study of 27 cases and comparison to conventional dedifferentiated liposarcomas and leiomyosarcomas.

Binh MB, Guillou L, Hostein I, Château MC, Collin F, Aurias A, Binh BN, Stoeckle E, Coindre JM.

Am J Surg Pathol. 2007 Oct;31(10):1557-66.

PMID:
17895758
7.

Can MDM2 and CDK4 make the diagnosis of well differentiated/dedifferentiated liposarcoma? An immunohistochemical study on 129 soft tissue tumours.

Aleixo PB, Hartmann AA, Menezes IC, Meurer RT, Oliveira AM.

J Clin Pathol. 2009 Dec;62(12):1127-35. doi: 10.1136/jcp.2009.070201.

PMID:
19946100
8.

Dedifferentiated liposarcoma with meningothelial-like whorls, metaplastic bone formation, and CDK4, MDM2, and p16 expression: a morphologic and immunohistochemical study.

Thway K, Robertson D, Thway Y, Fisher C.

Am J Surg Pathol. 2011 Mar;35(3):356-63. doi: 10.1097/PAS.0b013e31820832c1.

PMID:
21317707
9.
10.

Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.

de Vreeze RS, de Jong D, Tielen IH, Ruijter HJ, Nederlof PM, Haas RL, van Coevorden F.

Mod Pathol. 2009 Feb;22(2):223-31. doi: 10.1038/modpathol.2008.164. Epub 2008 Sep 26.

11.

Retroperitoneal liposarcoma with colonic involvement: a case report.

Sato Y, Yamamoto S, Fujita S.

Jpn J Clin Oncol. 2014 Apr;44(4):374-8. doi: 10.1093/jjco/hyu009. Epub 2014 Feb 20.

PMID:
24558126
12.

Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity.

Coindre JM, Hostein I, Maire G, Derré J, Guillou L, Leroux A, Ghnassia JP, Collin F, Pedeutour F, Aurias A.

J Pathol. 2004 Jul;203(3):822-30.

PMID:
15221942
13.

Oncogenesis and classification of mixed-type liposarcoma: a radiological, histopathological and molecular biological analysis.

de Vreeze RS, de Jong D, Koops W, Nederlof PM, Ariaens A, Haas RL, van Coevorden F.

Int J Cancer. 2011 Feb 15;128(4):778-86. doi: 10.1002/ijc.25390.

14.

Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma.

Horvai AE, DeVries S, Roy R, O'Donnell RJ, Waldman F.

Mod Pathol. 2009 Nov;22(11):1477-88. doi: 10.1038/modpathol.2009.119. Epub 2009 Sep 4.

15.

Most malignant fibrous histiocytomas developed in the retroperitoneum are dedifferentiated liposarcomas: a review of 25 cases initially diagnosed as malignant fibrous histiocytoma.

Coindre JM, Mariani O, Chibon F, Mairal A, De Saint Aubain Somerhausen N, Favre-Guillevin E, Bui NB, Stoeckle E, Hostein I, Aurias A.

Mod Pathol. 2003 Mar;16(3):256-62.

16.

Histological Classification and Immunohistochemical Evaluation of MDM2 and CDK4 Expression in Canine Liposarcoma.

Avallone G, Roccabianca P, Crippa L, Lepri E, Brunetti B, Bernardini C, Forni M, Olandese A, Sarli G.

Vet Pathol. 2016 Jul;53(4):773-80. doi: 10.1177/0300985815626573. Epub 2016 Mar 18.

PMID:
26993784
17.

MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.

Binh MB, Sastre-Garau X, Guillou L, de Pinieux G, Terrier P, Lagacé R, Aurias A, Hostein I, Coindre JM.

Am J Surg Pathol. 2005 Oct;29(10):1340-7.

PMID:
16160477
18.

Establishment and characterization of a novel dedifferentiated liposarcoma cell line, NDDLS-1.

Ariizumi T, Ogose A, Kawashima H, Hotta T, Li G, Xu Y, Hirose T, Endo N.

Pathol Int. 2011 Aug;61(8):461-8. doi: 10.1111/j.1440-1827.2011.02683.x. Epub 2011 Jun 22.

PMID:
21790860
19.

Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.

Sirvent N, Coindre JM, Maire G, Hostein I, Keslair F, Guillou L, Ranchere-Vince D, Terrier P, Pedeutour F.

Am J Surg Pathol. 2007 Oct;31(10):1476-89.

PMID:
17895748
20.

Detection of MDM2/CDK4 amplification in lipomatous soft tissue tumors from formalin-fixed, paraffin-embedded tissue: comparison of multiplex ligation-dependent probe amplification (MLPA) and fluorescence in situ hybridization (FISH).

Creytens D, van Gorp J, Ferdinande L, Speel EJ, Libbrecht L.

Appl Immunohistochem Mol Morphol. 2015 Feb;23(2):126-33. doi: 10.1097/PDM.0000000000000041.

PMID:
25679065

Supplemental Content

Support Center